litlas
ログインアカウント作成

Oliver W. Press

1982–2020 年に発表

95
論文数
18,955
被引用数
84
h 指数
95
i10 指数

被引用数

Oliver W. Press の年別被引用数1985 年: 被引用 1 件1986 年: 被引用 8 件1987 年: 被引用 4 件1988 年: 被引用 11 件1989 年: 被引用 15 件1990 年: 被引用 15 件1991 年: 被引用 14 件1992 年: 被引用 27 件1993 年: 被引用 23 件1994 年: 被引用 34 件1995 年: 被引用 32 件1996 年: 被引用 36 件1997 年: 被引用 36 件1998 年: 被引用 61 件1999 年: 被引用 56 件2000 年: 被引用 102 件2001 年: 被引用 129 件2002 年: 被引用 146 件2003 年: 被引用 179 件2004 年: 被引用 133 件2005 年: 被引用 177 件2006 年: 被引用 79 件2007 年: 被引用 132 件2008 年: 被引用 130 件2009 年: 被引用 108 件2010 年: 被引用 122 件2011 年: 被引用 119 件2012 年: 被引用 81 件2013 年: 被引用 108 件2014 年: 被引用 76 件2015 年: 被引用 137 件2016 年: 被引用 126 件2017 年: 被引用 148 件2018 年: 被引用 144 件2019 年: 被引用 445 件2020 年: 被引用 426 件2021 年: 被引用 326 件2022 年: 被引用 278 件2023 年: 被引用 180 件2024 年: 被引用 293 件2025 年: 被引用 129 件2026 年: 被引用 1 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,020 件、この内訳の 35.4%中国: 引用元論文 352 件、この内訳の 6.2%ドイツ: 引用元論文 350 件、この内訳の 6.1%イギリス: 引用元論文 349 件、この内訳の 6.1%イタリア: 引用元論文 260 件、この内訳の 4.6%フランス: 引用元論文 246 件、この内訳の 4.3%カナダ: 引用元論文 211 件、この内訳の 3.7%スイス: 引用元論文 158 件、この内訳の 2.8%オランダ: 引用元論文 154 件、この内訳の 2.7%スペイン: 引用元論文 147 件、この内訳の 2.6%オーストラリア: 引用元論文 139 件、この内訳の 2.4%日本: 引用元論文 117 件、この内訳の 2.1%
0%35.4%その他 21%

機関

分野

  • Medicine80.2%
  • Biochemistry, Genetics and Molecular Biology8.5%
  • Immunology and Microbiology4.8%
  • Materials Science2.2%
  • Health Professions1.6%
  • Engineering0.9%
  • その他1.8%

トピック

  • CAR-T cell therapy research10.6%
  • Lymphoma Diagnosis and Treatment10%
  • Monoclonal and Polyclonal Antibodies Research6.3%
  • Radiopharmaceutical Chemistry and Applications3.8%
  • Chronic Lymphocytic Leukemia Research3.4%
  • Immune Cell Function and Interaction3.4%
  • その他62.5%

共著者

全論文

検索で開く
  1. Radioimmunotherapy of human tumours

    著者: Steven M. Larson, Jorge A. Carrasquillo, Nai‐Kong V. Cheung, Oliver W. Press - Nature reviews. Cancer 2015 被引用: 538

  2. Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

    著者: Brian G. Till, Michael C. Jensen, Jinjuan Wang, Eric Chen, Brent L. Wood, Harvey A. Greisman, Xiaojun Qian, Scott E. James, Andrew Raubitschek, Stephen J. Forman, Ajay K. Gopal, John M. Pagel, Catherine Lindgren, Philip D. Greenberg, Stanley R. Riddell, Oliver W. Press - Blood 2008 被引用: 719

  3. Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study

    著者: Maria Corinna Palanca-Wessels, Myron S. Czuczman, Gilles Salles, Sarit Assouline, Laurie H. Sehn, Ian W. Flinn, Manish R. Patel, Randeep Sangha, Anton Hagenbeek, Ranjana H. Advani, Hervé Tilly, Olivier Casasnovas, Oliver W. Press, Sreeni Yalamanchili, Robert S. Kahn, Randall Dere, Dan Lü, Surai Jones, Cheryl Jones, Yu-Waye Chu, Franck Morschhauser - The Lancet Oncology 2015 被引用: 335

  4. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

    著者: Brian G. Till, Michael C. Jensen, Jinjuan Wang, Xiaojun Qian, Ajay K. Gopal, David G. Maloney, Catherine Lindgren, Yukang Lin, John M. Pagel, Lihua E. Budde, Andrew Raubitschek, Stephen J. Forman, Philip D. Greenberg, Stanley R. Riddell, Oliver W. Press - Blood 2012 被引用: 530

  5. Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

    著者: Franck Morschhauser, Ian W. Flinn, Ranjana H. Advani, Laurie H. Sehn, Catherine Diefenbach, Kathryn S. Kolibaba, Oliver W. Press, Gilles Salles, Hervé Tilly, Andy I. Chen, Sarit Assouline, Bruce D. Cheson, Martin Dreyling, Anton Hagenbeek, Pier Luigi Zinzani, Surai Jones, Ji Cheng, Dan Lü, Elicia Penuel, Jamie Hirata, Michael Wenger, Yu-Waye Chu, Jeff P. Sharman - The Lancet Haematology 2019 被引用: 249

  6. Temozolomide Nanoparticles for Targeted Glioblastoma Therapy

    著者: Fang Chen, Kui Wang, Zachary R. Stephen, Qingxin Mu, Forrest M. Kievit, Daniel T. Chiu, Oliver W. Press, Miqin Zhang - ACS Applied Materials & Interfaces 2015 被引用: 203

  7. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis

    著者: Adam M. Petrich, Mitul Gandhi, Borko Jovanovic, Jorge J. Castillo, Saurabh Rajguru, David T. Yang, Khushboo Shah, Jeremy D. Whyman, Frederick Lansigan, Francisco J. Hernandez‐Ilizaliturri, Lisa X. Lee, Stefan K. Barta, Shruthi Melinamani, Reem Karmali, Camille Adeimy, Scott E. Smith, Neil Dalal, Chadi Nabhan, David Peace, Julie M. Vose, Andrew M. Evens, Namrata Shah, Timothy S. Fenske, Andrew D. Zelenetz, Daniel J. Landsburg, Christina Howlett, Anthony R. Mato, Michael Jaglal, Julio C. Chávez, Judy Tsai, Nishitha Reddy, Shaoying Li, Caitlin E. Handler, Christopher R. Flowers, Jonathon B. Cohen, Kristie A. Blum, Kevin Song, Haowei Sun, Oliver W. Press, Ryan D. Cassaday, Jesse Jaso, L. Jeffrey Medeiros, Aliyah R. Sohani, Jeremy S. Abramson - Blood 2014 被引用: 466

  8. Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane

    著者: Scott E. James, Philip D. Greenberg, Michael C. Jensen, Yukang Lin, Jinjuan Wang, Brian G. Till, Andrew Raubitschek, Stephen J. Forman, Oliver W. Press - The Journal of Immunology 2008 被引用: 251

  9. Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes

    著者: Matthias Pfeifer, Bing Zheng, Tabea Erdmann, Hartmut Koeppen, Ronald McCord, Michael Grau, Annette M. Staiger, Akiko Chai, Thomas Sandmann, Hannelore Madle, Bernd Dörken, Y-W Chu, A I Chen, Dan I. Lebovic, Gilles Salles, M. S. Czuczman, Maria Corinna Palanca-Wessels, Oliver W. Press, Ranjana H. Advani, Franck Morschhauser, Bruce D. Cheson, Peter Lenz, German Ott, Andrew G. Polson, Kirsten Mundt, Georg Lenz - Leukemia 2015 被引用: 152

  10. Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

    著者: Laurie H. Sehn, Neil Chua, Jiřı́ Mayer, Gregg Dueck, Marek Trněný, Kamal Bouabdallah, Nathan Fowler, Vincent Delwail, Oliver W. Press, Gilles Salles, John G. Gribben, Anne Lennard, Pieternella J. Lugtenburg, Natalie Dimier, Elisabeth Wassner-Fritsch, Günter Fingerle‐Rowson, Bruce D. Cheson - The Lancet Oncology 2016 被引用: 343

  11. Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study

    著者: Bruce D. Cheson, Neil Chua, Jiřı́ Mayer, Greg Dueck, Marek Trněný, Kamal Bouabdallah, Nathan Fowler, Vincent Delwail, Oliver W. Press, Gilles Salles, John G. Gribben, Anne Lennard, Pieternella J. Lugtenburg, Günter Fingerle‐Rowson, Federico Mattiello, Andrea Knapp, Laurie H. Sehn - Journal of Clinical Oncology 2018 被引用: 167

  12. The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model

    著者: Shyril O’Steen, Melissa L. Comstock, Johnnie J. Orozco, Donald K. Hamlin, D. Scott Wilbur, Jon C. Jones, Aimee L. Kenoyer, Margaret E. Nartea, Yukang Lin, Brian W. Miller, Theodore A. Gooley, Sherilyn A. Tuazon, Brian G. Till, Ajay K. Gopal, Brenda M. Sandmaier, Oliver W. Press, Damian J. Green - Blood 2019 被引用: 56

  13. Optimizing Adoptive Polyclonal T Cell Immunotherapy of Lymphomas, Using a Chimeric T Cell Receptor Possessing CD28 and CD137 Costimulatory Domains

    著者: Jinjuan Wang, Michael C. Jensen, Yukang Lin, Xingwei Sui, Eric Chen, Catherine Lindgren, Brian G. Till, Andrew Raubitschek, Stephen J. Forman, Xiaojun Qian, Scott E. James, Philip D. Greenberg, Stanley R. Riddell, Oliver W. Press - Human Gene Therapy 2007 被引用: 213

  14. Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma

    著者: Lihua E. Budde, Carolina Berger, Yukang Lin, Jinjuan Wang, Xubin Lin, Shani E. Frayo, Shaunda A. Brouns, David M. Spencer, Brian G. Till, Michael C. Jensen, Stanley R. Riddell, Oliver W. Press - PLoS ONE 2013 被引用: 189

  15. A multicentre study of primary breast diffuse large B‐cell lymphoma in the rituximab era

    著者: Peter J. Hosein, Jocelyn Maragulia, Matthew Salzberg, Oliver W. Press, Thomas M. Habermann, Julie M. Vose, Martin Bast, Ranjana H. Advani, Robert Tibshirani, Andrew M. Evens, Nahida Islam, John P. Leonard, Peter Martin, Andrew D. Zelenetz, Izidore S. Lossos - British Journal of Haematology 2014 被引用: 114

  16. Quantitative single‐particle digital autoradiography with α‐particle emitters for targeted radionuclide therapy using the iQID camera

    著者: Brian W. Miller, Sofia H.L. Frost, Shani L. Frayo, Aimee L. Kenoyer, Erlinda B. Santos, Jon C. Jones, Damian J. Green, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, Johnnie J. Orozco, Oliver W. Press, John M. Pagel, Brenda M. Sandmaier - Medical Physics 2015 被引用: 77

  17. 90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma

    著者: Sherilyn A. Tuazon, Brenda M. Sandmaier, Theodore A. Gooley, Darrell R. Fisher, Leona Holmberg, Pamela S. Becker, Sally J. Lundberg, Johnnie J. Orozco, Ajay K. Gopal, Brian G. Till, David G. Coffey, Margaret E. Nartea, Manuela C. Matesan, John M. Pagel, Joseph G. Rajendran, Oliver W. Press, William Bensinger, Damian J. Green - Bone Marrow Transplantation 2020 被引用: 20

  18. Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies

    著者: Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press - Blood 1998 被引用: 571

  19. Allogeneic hematopoietic cell transplantation after conditioning with 131I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

    著者: John M. Pagel, Theodore A. Gooley, Joseph G. Rajendran, Darrell R. Fisher, Wendy Wilson, Brenda M. Sandmaier, Dana C. Matthews, H. Joachim Deeg, Ajay K. Gopal, Paul J. Martin, Rainer Storb, Oliver W. Press, Frederick R. Appelbaum - Blood 2009 被引用: 185

  20. A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts

    著者: Oliver W. Press, Melissa C. Corcoran, Krishnan Subbiah, Don K. Hamlin, D. Scott Wilbur, Timothy A. Johnson, Louis Theodore, Eric Kin Cheong Yau, Robert W. Mallett, Damon L. Meyer, Don B. Axworthy - Blood 2001 被引用: 149

  21. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2015

    著者: Andrew D. Zelenetz, Leo I. Gordon, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, Charalambos Andreadis, Nancy L. Bartlett, John C. Byrd, Myron S. Czuczman, Luis Fayad, Richard I. Fisher, Martha Glenn, Thomas M. Habermann, Nancy L. Harris, Richard T. Hoppe, Steven M. Horwitz, Chris R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver W. Press, Rachel Rabinovitch, Nishitha Reddy, Erin Reid, Ayman Saad, Lubomir Sokol, Lode J. Swinnen, Christina Tsien, Julie M. Vose, Lynn D. Wilson, Joachim Yahalom, Nadeem Zafar, Mary A. Dwyer, Hema Sundar - Journal of the National Comprehensive Cancer Network 2015 被引用: 78

  22. Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia

    著者: Phuong Vo, Ted Gooley, Joseph G. Rajendran, Darrell R. Fisher, Johnnie J. Orozco, Damian J. Green, Ajay K. Gopal, Robyn L. Haaf, Margaret E. Nartea, Rainer Storb, Frederick R. Appelbaum, Oliver W. Press, John M. Pagel, Brenda M. Sandmaier - Haematologica 2019 被引用: 31

  23. Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

    著者: Mark Kaminski, Andrew D. Zelenetz, Oliver W. Press, Mansoor N. Saleh, John P. Leonard, Louis Fehrenbacher, T. Andrew Lister, Robert Stagg, George F. Tidmarsh, Stew Kroll, Richard L. Wahl, Susan J. Knox, Julie M. Vose - Journal of Clinical Oncology 2001 被引用: 586

  24. US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816

    著者: Oliver W. Press, Hongli Li, Heiko Schöder, David J. Straus, Craig H. Moskowitz, Michael LeBlanc, Lisa M. Rimsza, Nancy L. Bartlett, Andrew M. Evens, Erik Mittra, Ann S. LaCasce, John Sweetenham, Paul M. Barr, Michelle A. Fanale, Michael V. Knopp, Ariela Noy, Eric D. Hsi, James R. Cook, Mary Jo Lechowicz, Randy D. Gascoyne, John P. Leonard, Brad S. Kahl, Bruce D. Cheson, Richard I. Fisher, Jonathan W. Friedberg - Journal of Clinical Oncology 2016 被引用: 266